(Q37362740)

19 August 2017

1 reference

title

PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury (English)

1 reference

19 August 2017

1 reference

1 reference

Christoph Thiemermann

series ordinal

3

object named as

Christoph Thiemermann

1 reference

19 August 2017

Massimo Collino

1

1 reference

PubMed ID

19124421

19 August 2017

Nimesh S A Patel

series ordinal

2

1 reference

19 August 2017

1 June 2008

1 reference

Therapeutic advances in cardiovascular disease

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

3

1 reference

19 August 2017

179-197

1 reference

Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor beta-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Protein S100B release from rat brain slices during and after ischemia: comparison with lactate dehydrogenase leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Role of CBP/P300 in nuclear receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Reactive oxygen radicals in signaling and damage in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

TNFalpha downregulates PPARdelta expression in oligodendrocyte progenitor cells: implications for demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Stroke and neurovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Troglitazone induces CYP3A4 activity leading to falsely abnormal dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor γ activators inhibit interleukin-12 production in murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Acute stroke: pathophysiology, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The effects of diquat and ciprofibrate on mRNA expression and catalytic activities of hepatic xenobiotic metabolizing and antioxidant enzymes in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Combinatorial roles of nuclear receptors in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Animal models of stroke: do they have value for discovering neuroprotective agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Therapeutic strategies for the treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPARgamma and metabolism: insights from the study of human genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Cholesterol predicts stroke mortality in the Women's Pooling Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The role of hyperglycemia in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPARalpha agonist-induced rodent tumors: modes of action and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Characterization of superoxide production sites in isolated rat brain and skeletal muscle mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Brain tissue responses to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

15d-prostaglandin J2 protects brain from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Molecular targets in cerebral ischemia for developing novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

A unified nomenclature system for the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Novel sequence determinants in peroxisome proliferator signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Nuclear receptors versus inflammation: mechanisms of transrepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Dual Peroxisome Proliferator-Activated Receptor-alpha/gamma Agonists : In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPARs and molecular mechanisms of transrepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The role of fibrates in the prevention of cardiovascular disease--a pooled meta-analysis of long-term randomized placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Prospects for the future: the role of free radicals in the treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Solution structure of the DNA-binding domain of the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPARalpha-dependent modulation of hepatic CYP1A by clofibric acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Bcl-2 and Bax proteins are increased in neocortical but not in thalamic apoptosis following devascularizing lesion of the cerebral cortex in the rat: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Altered PPARgamma expression and activation after transient focal ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxicity to HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708090924

21 January 2018

Identifiers

DOI

10.1177/1753944708090924

1 reference

19 August 2017

1 reference

PubMed ID

19124421